Shigemi Sasawatari et al.
Journal of immunology (Baltimore, Md. : 1950), 204(5), 1373-1385 (2020-01-24)
Adoptive cellular therapy and its derivative, chimeric AgR T cell therapy, have achieved significant progress against cancer. Major barriers persist, however, including insufficient induction of cytotoxic T cells and exhaustion of tumor-infiltrating lymphocytes. In this study, we discovered a new